evocalcet
Small moleculeexperimental
Clinical trial activity
9 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
6
Phase 3
5
Phase 4
0
Earliest trial started Aug 1, 2013 (NCT01935856)
Timeline
Indications
Mechanism of action
- Calcium sensing receptorPOSITIVE ALLOSTERIC MODULATOR
Calcium sensing receptor positive allosteric modulator
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
C[C@@H](N[C@H]1CCN(c2ccc(CC(=O)O)cc2)C1)c1cccc2ccccc12- Mol. weight
- 374.48 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297621 ↗
Also known as
- evocalcet
- khk7580
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04206657 | Phase 1 | Dec 31, 2019 | Kyowa Hakko Kirin |
| NCT03822507 | Phase 3 | Apr 9, 2019 | Kyowa Hakko Kirin |
| NCT03280264 | Phase 3 | Aug 30, 2017 | Kyowa Hakko Kirin |
| NCT02549404 | Phase 3 | Sep 1, 2015 | Kyowa Hakko Kirin |
| NCT02549391 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2015 | Kyowa Hakko Kirin |
| NCT02549417 | Phase 3 | Sep 1, 2015 | Kyowa Hakko Kirin |
| NCT02216656 | Phase 2 | Jul 1, 2014 | Kyowa Hakko Kirin |
| NCT02143271 | Phase 1 | May 1, 2014 | Kyowa Hakko Kirin |
| NCT01935856 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2013 | Kyowa Hakko Kirin |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kyowa Hakko Kirin | For profit | 9 | 9 | 3 | 2013 |
1 organizations
Page 1 / 1